deoxyglucose has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubert, I; Bezard, E; Bioulac, BH; Bloch, B; Crossman, AR; Dovero, S; Gross, CE; Guigoni, C; Li, Q | 1 |
| Benazzouz, A; Bezard, E; Bioulac, BH; Cirilli, L; Garret, M; Gross, CE; Guigoni, C; Meissner, W | 1 |
2 other study(ies) available for deoxyglucose and Parkinsonian Disorders
| Article | Year |
|---|---|
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Topics: Animals; Basal Ganglia; Deoxyglucose; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Levodopa; Limbic System; Macaca fascicularis; Motor Cortex; Parkinsonian Disorders; Septal Nuclei; Somatosensory Cortex; Substantia Nigra; Subthalamic Nucleus | 2005 |
Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease.
Topics: Animals; Basal Ganglia; Deoxyglucose; Disease Models, Animal; Dose-Response Relationship, Radiation; Electric Stimulation Therapy; Electron Transport Complex IV; Female; Gene Expression Regulation; Macaca fascicularis; Parkinsonian Disorders; RNA, Messenger; Statistics, Nonparametric; Subthalamic Nucleus | 2007 |